Friday, November 16, 2018

Treatment For Mesothelioma Patients: Scan Challenge Of Pleural Effusion

Treatment Mesothelioma. The early identification of the fatal and incurable mesothelioma and the subsequent granting of the radiation, surgery, and palliative care asbestosis are known to help the patient the best opportunity to expand and improve the quality of life of the remaining.

The critical factor in this process is the use of the scanning technology of the body, from x-rays, mri (magnetic resonance imaging), ct (computed tomography) scan or ct scan, the most advanced pet/ct (positron emission tomography and computed tomography).

A prolonged period of grace of up to 50 years after the first exposure to asbestos and the inhalation of fibers, dust on the appearance of asbestosis of symptoms can often mean that a diffuse malignant mesothelioma has reached an advanced stage, and the distribution in other tissues of the authority.

While an x-ray of the chest or in the abdomen, we may detect the accumulation of fluid, mass, or signs of non-cancerous of the disease of the pleura, the proof of the spreading of the tumor of expansion of the x-ray will only show, as the shadow of a drive of a tumor, such as with peritoneal of mesothelioma. In the same way, despite the mri supply highly detailed image of the inside of the body, and can determine the severity of the tumor, this type of analysis up to now, it can’t be the only testimony about the cancer.

The tc of the image of the products on offer in the cross-section of the examination of the layers of the body for more easy to detect deviations from the given depth in the body of the patient, and can also identify and diagnose lung cancer before an x-ray of chest, which leads to the improvement of survival in 20%. However, ct can detect pleural effusion, plevralnaya the court, calcification of the pleura or the chest wall of a possible invasion, which cannot differentiate between benign or malignant tumors of mesothelioma.

Mesothelioma patients who suffer painful breathing caused by pleural effusions – fluid accumulation through the lung linings in response to the spread of tumors mesothelioma – you can go through the procedure of drainage of liquids and replace the space with the health services of the talc.

New medical studies have found that the fluid draining process may interfere with the pet/ct follow-up, which also involves the establishment of a patient radioactive locator and the level of absorption of cancer cells, subsequently, to evaluate the results of the validation, once after 14 days and then again after 125 days.

It was found that increasing the number of tracer is absorbed by the cancerous cells, the talc, the treatment may appear to show the disease spreads faster than your true progress.

The researchers came to the conclusion that, to compensate for the interference with the evaluation of several modified method of the interpretation of the results of the analysis is recommended for patients of mesothelioma of the pleura, which receive the drainage and talc procedure.

Mesothelioma Treatments - Malignant Mesothelioma, Asbestos

Mesothelioma treatments have been unsuccessful in combating malignant mesothelioma. The failure of mesothelioma treatments to eradicate the disease could be attributed to the short post-diagnosis survival time of malignant mesothelioma patients (one to two years). Once diagnosed, malignant mesothelioma is typically in an advanced stage, limiting the effect that mesothelioma treatments can have.

Although asbestos lung cancer is often asymptomatic in its early stages, it can be diagnosed long before reaching an advanced stage. This creates a larger window of opportunity for treatment to take place, increasing treatment options. The longer a patient can receive treatment, the greater the chance of success.

Traditional Mesothelioma Treatments

Mesothelioma treatments are broken down into two categories: traditional treatments and new treatments.

Traditional mesothelioma treatments are similar to other standard cancer treatment modalities. Two or more traditional mesothelioma treatments are often used together to better combat cancerous cells.

Traditional mesothelioma treatments include:

  • Surgery
  • Chemotherapy
  • Radiation therapy (radiotherapy)

Surgery

Surgical treatment is one of the oldest methods used to combat cancer. Surgical mesothelioma treatments involve the physical removal of a cancerous mass from a malignant mesothelioma patient.

There are three categories of surgical treatment:

  • Diagnostic surgery: used to provide a conclusive mesothelioma diagnosis. A biopsy is a diagnostic surgery that involves the surgical removal of diseased tissue for examination by a histopathologist.
  • Palliative surgery: used to treat a symptom of a disease without treating the disease itself. For example, fluid build-up in the chest (pleural effusion) is a common and painful symptom of pleural mesothelioma. A palliative surgical procedure treating pleural effusion is a thoracoscopy, the draining of fluid from the chest.
  • Potentially curative surgery: is performed with "curative intent," typically involving the removal of large amounts of diseased tissue. For example, an extrapleural pneumonectomy is a potentially curative mesothelioma surgery used to treat pleural mesothelioma. The highly invasive procedure involves the removal of cancerous pleural tissue in addition to an entire lung.

Chemotherapy

Chemotherapy mesothelioma treatments use chemical substances (drugs) to treat cancerous cells. Cancer cells are different from normal cells in that they divide and multiply in an uncontrolled fashion, allowing the disease to grow and spread rapidly. Anticancer chemotherapy drugs are developed to inhibit the spread of cancer by introducing elements of control to the otherwise uncontrollable cells.

Cisplatin is a platinum-based chemotherapy drug used to treat a variety of cancers including sarcomas, carcinomas, lymphomas and mesothelioma (when in combination with other chemotherapy drugs). Cisplatin functions culminate in programmed cellular death (apoptosis) for targeted cancer cells by preventing rapidly dividing cells to duplicate DNA.

New malignant mesothelioma treatments revolve primarily around the development and implementation of new chemotherapy drugs like Alimta (commonly used with cisplatin), Veglin and Onconase.

Radiation Therapy (Radiotherapy)

Radiotherapy mesothelioma treatments use high-energy particle beams (radiation waves) to kill cancerous cells. Radiotherapy is often used palliatively for the purpose of relieving certain malignant mesothelioma symptoms such as pain or shortness of breath.

Radiation therapy can have a negative effect on healthy tissue surrounding treated cancer cells. Intensity modulated radiation therapy (IMRT) was therefore designed with the intention of providing a more targeted system of radiotherapy, limiting the amount of healthy tissue exposed to radiation.

Malignant Mesothelioma Surgery - Pericardial Mesothelioma

Potentially Curative Malignant Mesothelioma Surgery

Malignant mesothelioma surgery has had limited success in treating this rare type of cancer. Malignant mesothelioma affects the mesothelial tissue of three large body cavities and is responsible for an estimated 200,000 deaths worldwide. A positive malignant mesothelioma diagnosis will yield one of three distinct types of the disease: pleural mesothelioma, peritoneal mesothelioma or pericardial mesothelioma.

Malignant mesothelioma surgery is one of three traditional mesothelioma treatments; chemotherapy and radiotherapy are the other two. Mesothelioma surgery is the most proactive of the treatments because it involves the physical removal of a cancerous mass from the body.

There are three mesothelioma surgery categories:

  1. Diagnostic surgery: used to validate a mesothelioma diagnosis.
  2. Palliative surgery: used to treat the symptoms of a disease as opposed to the disease itself.
  3. Potentially curative surgery: administered with "curative intent" and often highly invasive.

Mesothelioma Surgery -- Pleurectomy

A pleurectomy decortication is the less invasive of the two types of potentially curative mesothelioma surgery. In short, a pleurectomy is a mesothelioma surgery through which the pleura (mesothelial tissue lining the lung cavity) is removed. Pleural mesothelioma causes cancerous cellular growth in the pleura and can spread (metastasize) to other parts of the body. Pleurectomy decortication surgery is an option only for early-stage pleural mesothelioma patients whose tumor has not yet invaded the lung tissue itself.

Though potentially curative, pleurectomy decortication mesothelioma surgery is also used palliatively to treat some of the nagging symptoms associated with pleural mesothelioma. The procedure can help to reduce pain caused by pleural tumor mass or serve as a preventative measure against fluid build-up in the chest (pleural effusion), a common symptom of pleural mesothelioma.

Extrapleural Pneumonectomy

An extrapleural pneumonectomy is the more extensive and invasive of the two types of potentially curative mesothelioma surgery. An extrapleural pneumonectomy involves the removal of sections of the diaphragm and pericardium in addition to removal of the pleura and lung most affected by the cancer.

An extrapleural pneumonectomy can require a hospital stay of five to ten days, during which patients will receive a variety of postoperative treatments designed to manage pain and rehabilitate affected organs (most notably the heart). Though an extreme measure, extrapleural pneumonectomy mesothelioma surgery has the potential to increase pleural mesothelioma patients' survival time by as much as five years.

Pneumonectomy surgery is used to treat certain types of lung cancer, including asbestos lung cancer; however, a pneumonectomy strictly involves the removal of the diseased lung.

Combination Therapy

Mesothelioma surgery is typically used in conjunction with one or more additional mesothelioma treatments. Each mesothelioma treatment has its own technique for combating malignant mesothelioma cancer cells. It is believed that a combination of these various techniques provides a greater chance for treatment success.

For example, chemotherapy treatment is often administered for several weeks to slow the spread of malignant mesothelioma cancer cells prior to surgical treatment. This is done with the intention of providing a certain degree of containment around the cancerous mass before removal. Radiation therapy is often used postoperatively to kill any lingering tumor cells. A three-pronged approach is more effective than removal of the tumor alone.

Malignant Pleural Mesothelioma - Asbestos Product

Mesothelioma Reference Center

Our feature article “Mesothelioma: A Historical Perspective”, will give you a better understanding of the treatments available for anyone suffering from Mesothelioma.

Mesothelioma affects the linings of the cavities around the lungs, stomach, and heart. It is caused by inhaling asbestos fibers, but the cancer usually does not appear until 10 to 40 years after a person first inhales asbestos.

The existence of malignant mesothelioma as a primary tumor of the pleural, peritoneum, pericardium, and other organs has long been controversial. As early as 1767, however, Joseph Lieutaud is credited with describing two cases of probable mesothelioma in a study of 3,000 autopsies, and E. Wagner recognized the disease as a pathologic entity in 1870.238,239,298 Klemperer and Rabin described in detail the histologic features of benign (localized) and malignant (diffuse) mesotheliomas in 1931.143

A case record of malignant pleural mesothelioma discussed in 1947 led neither to the recognition of the diagnosis nor to the suspicion of asbestos as a causative factor, even though the introductory sentence included the term asbestos worker, and later the patient's work was described as 'cutting asbestos insulating board."48 This controversy lasted until 1960, when the major etiologic factor (i.e., asbestos) was established in a seminal report by J. C. Wagner and colleagues in 32 of 33 cases of mesothelioma, largely by environmental exposure in the 'Asbestos Hills" of Cape Province in South Africa.295 Such a singular relationship, confirmed in many other countries including the United States, established the disease as a distinct nosologic entity.236

Incidence and Epidemiology


Mesothelioma has been such a rare disease, or one recognized so infrequently, that it has not been coded as a separate cause of death and has been seriously underestimated in mortality statistics.71,236 The age-adjusted incidence of pleural and peritoneal mesothelioma in the United States has been estimated at 14.2 per million per year, with almost a three-fold increase for pleural mesothelioma in Caucasian males between 1973 and 1984.71 The male-female ratio is about 4:1, and 80% arise from the pleura.71 Cases tend to be clustered in areas of asbestos product plants and shipbuilding facilities.94 Similar trends have been reported in other industrialized countries, such as England. 104 In autopsy studies, the frequency of malignant mesothelioma varies from 0.02 to 0.7%, with a rate of 0.2% in the largest series.127

In most hospital series, the pleura is more often involved than the peritoneum, with a predominance of the right side over the left (60:40).127 In some epidemiologic studies monitoring cohorts of asbestos workers, however, the peritoneal form is more common than the pleural.238 The mean age of patients is approximately 60 years,16,93,214,305 but the disease can occur at any age, including in childhood.116 In a review of 80 children with a diagnosis of malignant mesothelioma, the mean age was 9.7 years, and 59% were male. Only 2 children were noted to have a history of possible asbestos exposure, 1 had received radiotherapy for Wilms' tumor, and 1 had been exposed to isoniazid in utero.102

Mesothelioma Treatments

Traditional mesothelioma treatment options include surgery, chemotherapy and radiation therapy. Traditional treatments are also used to combat other types of cancer such as asbestos lung cancer, carcinomas, sarcomas, lymphomas, etc.

New mesothelioma treatment options include new chemotherapy agents, photodynamic therapy (PDT), immunotherapy, mesothelioma gene therapy and intensity modulated radiation therapy (IMRT).

Asbestos Exposure - Asbestosis, Fibrosis

Etiology


A unique feature of mesothelioma is its strong relationship with asbestos exposure, which has recently led to great public concern in view of the ubiquitous presence of that mineral.


Epidemiologic and Clinical Evidence of the Role of Asbestos


Many epidemiologic surveys around the world have revealed prior exposure to asbestos in about 70 to 80% of all cases of mesothelioma when a careful history was taken.16,63,192,305 Beginning 15 years after onset of exposure, about 6% of asbestos workers over the age of 35 years die of mesothelioma.238 The death rate from mesothelioma in a cohort of asbestos insulation workers was 344 times higher than in the general population.236

It is estimated that, from 1940 through 1979, approximately 27.5 million workers were occupationally exposed to asbestos in the United States, with a calculated annual death rate from mesothelioma of about 2,000 in 1980 up to 3,000 in the late 1990s.190 Exposure can be not only occupational but also environmental, or even familial by household contamination. The latter type of exposure, usually through the work clothes of an asbestos worker, is an important factor for women. It was also found in 5 of 10 young adults (40 years or younger) with mesothelioma who had been exposed in childhood.134 Insulation, construction, shipyard industries, and automobile brakes are among the many sources of occupational exposure. The delay between first exposure and onset of the disease is extremely long, averaging 30 to 45 years, with a usual range of 10 to 65 years and a standard deviation of 12 years.63,238,305 Because of such a delay, asbestos exposure can easily be underestimated, since occupational histories are often inadequately documented.

197,280 Moreover, exposure may have been short or minimal, 63,238 although sometimes a very short exposure may have been intense.306 Pulmonary asbestosis and fibrosis are often absent or are rarely severe and are found at autopsy in about 40% of patients with mesothelioma.16,63 Due to the long latency and to the vastly increased use of asbestos during and after World War II, the incidence of mesothelioma is expected to continue to increase.190 Although asbestos exposure and cigarette smoking act synergistically to produce bronchogenic carcinoma, smoking is not a factor for mesothelioma.183,192,238,291 The presence of asbestos fibers in sections of lung tissue is another proof of asbestos exposure. Asbestos fibers are more difficult to detect in mesothelioma tissues than in the pulmonary parenchyma. Fibers in tissues can acquire a proteinaceous coating containing iron, leading to the formation of ferruginous bodies.238 These are not specific and can be called asbestos bodies only if the central core is identified as being asbestos. The asbestos minerals are divided into two major categories: the serpentines (chrysotile) with a general formula Mg3Si2O5(OH)4, forming long hollow tubes, and the amphiboles containing more silica and less magnesium oxide and forming short, straight fibers.238 Among the various types of asbestos associated with mesothelioma, amphiboles carry the highest risk: crocidolite in South Africa, and amosite in the United States have been most commonly incriminated.

127,183,293 Chrysotile, a long, curly fiber with poor pulmonary penetration which can be dissolved in lung tissue, seems to carry a much lower risk, although it does not appear to be nil.68,218,293 It has been postulated that mesotheliomas occurring in chrysotile-exposed individuals may be related to contamination by tremolite,68 another amphibole fiber which has been implicated in cases of mesothelioma in Greece,150 and which may contaminate other substances, such as talc or vermiculite.177 On the other hand, another amphibole fiber mined in Finland, anthophyllite, a thick coarse fiber, has been shown to cause calcified pleural plaques but usually not mesothelioma.127

These data emphasize the importance of the type of fiber and its physical characteristics and also the fact that most natural asbestos fibers are rarely pure but mixed.127 Although asbestos fibers can be detected in essentially 100% of the lungs of city dwellers by using special techniques,151 their number is markedly greater in the lungs of patients with mesothelioma and occupational exposure to asbestos, commonly reaching several million fibers per gram of dry weight.16 This is particularly true when amphibole fibers are counted.183 The mean increase of lung fiber burden of mesothelioma patients as compared with controls was seven times higher for pleural and 16 times higher for peritoneal mesothelioma but was lower than for patients with asbestosis (48 times higher than controls) or lung cancer with asbestos exposure (32 times higher than controls).

293 The question of a dose-response relationship between exposure to asbestos and occurrence of mesothelioma has been suggested by indirect methods, such as duration of employment in asbestos factories, or by quantitative measurements of pulmonary asbestos burden,63 especially if amphibole fibers > 10 microns are considered.218 No safe threshold has been established for asbestos exposure, however, and the asbestos burden in the lungs of mesothelioma patients forms a continuum that totally overlaps with controls at the lower end.

Mesothelioma Patients - Mesothelial Cells

Experimental Evidence for Role of Asbestos


Animal experiments have confirmed the oncogenicity of asbestos. A singleexplanation for the pathogenesis of mesothelioma. Normal human mesothelial cells can phagocytose asbestos fibers and are 10 times more sensitive than normal human bronchial epithelial cells to asbestos cytotoxicity in vitro.153 Mesothelial cells are 100 times more sensitive than fibroblasts.

Following in vitro exposure to asbestos, mesothelial cells display chromosomal aberrations indicative of clonal origin.153 Occurrence of DNA strand breaks has been found after exposure of cells to asbestos in vitro.131,159 Such effects could further lead to activation of oncogenes and/or loss of suppressor genes.23 Indeed, karyotypic analyses of human mesotheliomas have revealed frequent abnormalities, particularly involving chromosomes 1, 2, 3, 6, 7, 9, 11, 17, and 22.23,109,183,200 One of the most common nonrandom changes is deletion of the short arm of chromosome 3 between the region of p14 to 21.200

This finding is of interest, especially since deletions and loss of heterozygosity of the short arm of chromosome 3 have been reported also in lung cancer, particularly the small cell type in the region of p14 to 23,302 suggesting evidence for a suppressor gene important in respiratory carcinogenesis.

A significant correlation exists between chromosomal aberrations and pulmonary asbestos fiber burden in patients with mesothelioma.268 An inverse correlation between survival and the number of copies of chromosome 7 short arms has been reported.268 These cytogenetic changes may also be important in explaining the likely constitutional susceptibility to mesothelioma (see below).

Exposure of normal human mesothelial cells to asbestos fibers in vitro has as yet been unsuccessful in producing mesothelioma.153,183 Malignant transformation was achieved in one experiment by first transfecting cells with a plasmid containing the simian virus SV40, resulting in immortalization, followed by transfection with the EJ-ras gene, resulting in tumorigenicity.208 Exposure to asbestos failed to produce tumorigenicity, however. It may be extremely difficult to realize in vitro all the different conditions and interactions which may operate in vivo.

The existence of transforming genes has been detected in human mesothelioma, but their exact nature remains to be identified.23,149 They do not seem to be related to the ras gene family, which was found activated in 50% of asbestos-induced Syrian hamster tumor cell lines,23 or to the myc, myb, neu, or fos oncogenes.101 Loss of heterozygosity for the p53 gene located on the short arm of chromosome 17 has recently been observed in three of four mesothelioma cell lines.72

In another study of 20 cell lines from 17 patients with malignant mesothelioma, p53 abnormalities were found in three lines only.180 Wilms' tumor suppressor gene (WT-1) transcripts were found to be expressed in normal human mesothelial cells and in 7 of 7 human mesothelioma cell lines.297 Recently, changes in another suppressor gene, p16, were described, with homozygous deletions in 85% of mesothelioma cell lines and 22% of primary tumor specimens.65

Asbestos fibers can also transfect cells by binding to exogenous nucleic acids, such as plasmid DNA, which then becomes associated with chromosomal DNA, thereby altering gene expression.14 Knowledge of the role of growth factors in the genesis and proliferation of mesothelioma is rapidly expanding. The role of plateletderived growth factors (PDGF) has been emphasized.108 Mesothelioma cells express messenger RNAs (mRNAs) for both PDGF-A and -B chains at higher levels than normal human mesothelial cells, whereas the reverse is true for transforming growth factor-‰ (TGF-‰), suggesting that PDGF may be an autocrine growth factor for mesothelioma.

108 The corresponding genes for PDGF-A and PDGF-B (which is almost identical to the c-sis gene) are located on chromosomes 7p21 to p22 and 22q13.1, respectively, and although visible abnormalities of these chromosomes are not constant in mesothelioma, alterations at a molecular level cannot be excluded.108,278 Human mesothelioma cell lines, compared with normal human mesothelial cells, have shown strongly increased expression of the c-sis oncogene (PDGF-B) and to a lesser degree of the gene for PDGF-A.278

Normal mesothelial cell lines seem to express PDGF-‡ receptor genes, whereas mesothelioma cell lines express predominantly PDGF-‰ receptor genes.279 These findings could conceivably provide also a role for the thrombocytosis commonly observed in mesothelioma patients, in view of its negative prognostic influence.62,63,225 No increased expression of epidermal intrapleural or intraperitoneal injection of various asbestos fibers (chrysotile or amphibole) produce mesotheliomas in rats, hamsters, and mice, often after a relatively long delay of 7 months or more.261

Intratracheal instillation or inhalation is less often successful.25,290 Physical characteristics, rather than chemical properties, are incriminated, since many durable fibers of similar size and shape but of different nature (glass, aluminum oxide, talc, attapulgite) can also produce mesothelioma in animals.167,251 The most oncogenic fibers are the long, thin ones, with a length > 8 microns and a diameter < 0.25 micron, the so-called Stanton hypothesis, whereas shorter fibers may be inactivated by phagocytosis.117,251 These long, thin fibers may penetrate deep in the lung parenchyma,117,221,251 eventually reaching the subpleural and pleural structures and penetrating into cells without killing them, thereby implementing a complex oncogenic process.

The effect of gravity on inhaled fibers may explain the predominance of pleural mesothelioma in the lower thorax and on the right side.138 The pathogenesis of peritoneal mesothelioma is more obscure. Although the disease has not been produced in animals by feeding experiments, ingestion of asbestos fibers is likely to occur through the action of the tracheobronchial mucociliary apparatus, and these fibers may penetrate the gastrointestinal mucosa.138 Alternatively, retrograde spread to the peritoneal cavity from the pleura may take place.85 In fact, autopsy studies have revealed that asbestos fibers are found in many organs besides the lungs, including the spleen, thyroid, pancreas, heart, adrenals, kidneys, liver, prostate, and even brain.17

The possibility that asbestos exposure increases the risk of other cancers besides mesothelioma and lung cancer has been reviewed.85 The evidence is strong for laryngeal cancer (relative risk 1.4), suggestive but not conclusive for esophageal cancer, possible for renal cancer, and inconclusive for gastrointestinal, pancreatic, and ovarian cancers (where misdiagnosis of mesothelioma is difficult to exclude). There appears also to be no overall association with lymphomas, except possibly with large cell lymphomas of the oral cavity and gastrointestinal tract (see below).